CVS Health Corporate/ Other — Other segment items increased by 26.3% to $648.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 41.5%, from $458.00M to $648.00M. Over 3 years (FY 2022 to FY 2025), Corporate/ Other — Other segment items shows relatively stable performance with a 2.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in expenses indicates higher corporate overhead, while a decrease suggests improved cost control or one-time gains.
This represents miscellaneous expenses or income items within the corporate segment that do not fit into standard catego...
Common in large conglomerates to capture unallocated corporate costs.
cvs_segment_corporate_other_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $475.75M | $475.75M | $475.75M | $475.75M | $412.00M | $412.00M | $412.00M | $412.00M | $391.00M | $436.00M | $402.00M | $458.00M | $432.00M | $483.00M | $513.00M | $648.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -13.4% | +0.0% | +0.0% | +0.0% | -5.1% | +11.5% | -7.8% | +13.9% | -5.7% | +11.8% | +6.2% | +26.3% |
| YoY Change | — | — | — | — | -13.4% | -13.4% | -13.4% | -13.4% | -5.1% | +5.8% | -2.4% | +11.2% | +10.5% | +10.8% | +27.6% | +41.5% |